Rheumatology Clinic, Department of Medical and Surgical Sciences, University of Foggia, 71122 Foggia, Italy.
Int J Mol Sci. 2022 May 22;23(10):5804. doi: 10.3390/ijms23105804.
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by a wide variability of clinical manifestations due to the potential involvement of several tissues and internal organs, with a relapsing and remitting course. Dysregulation of innate and adaptive immune systems, due to genetic, hormonal and environmental factors, may be responsible for a broad spectrum of clinical manifestations, affecting quality of life, morbidity and mortality. Bone involvement represents one of the most common cause of morbidity and disability in SLE. Particularly, an increased incidence of osteoporosis, avascular necrosis of bone and osteomyelitis has been observed in SLE patients compared to the general population. Moreover, due to the improvement in diagnosis and therapy, the survival of SLE patient has improved, increasing long-term morbidities, including osteoporosis and related fractures. This review aims to highlight bone manifestations in SLE patients, deepening underlying etiopathogenetic mechanisms, diagnostic tools and available treatment.
系统性红斑狼疮(SLE)是一种慢性自身免疫性疾病,由于可能涉及多个组织和内部器官,具有复发性和缓解性病程,其临床表现具有很大的可变性。由于遗传、激素和环境因素,先天和适应性免疫系统的失调可能导致广泛的临床表现,影响生活质量、发病率和死亡率。骨骼受累是 SLE 患者发病率和残疾的最常见原因之一。与普通人群相比,SLE 患者中观察到骨质疏松症、骨坏死和骨髓炎的发病率增加。此外,由于诊断和治疗的改善,SLE 患者的生存率得到了提高,增加了长期的发病率,包括骨质疏松症和相关骨折。这篇综述旨在强调 SLE 患者的骨骼表现,深入探讨潜在的发病机制、诊断工具和可用的治疗方法。